Jinhe Biotechnology CO., LTD.

002688

CNE100001HK7

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 14/06/2024 am IST			5-day change	1st Jan Change
3.75 ^CNY	+1.63%		-2.60%	-22.04%

24/05	Jinhe Biotechnology CO., LTD. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 31 May 2024	CI
28/04	Jinhe Biotechnology CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Jinhe Biotechnology Co., Ltd. Elects Wang Zhisheng as Director

January 14, 2013

Jinhe Biotechnology Co., Ltd. announced that at the EGM held on January 11, 2013, the shareholders elected Wang Zhisheng as director.

Latest news about Jinhe Biotechnology CO., LTD.

Jinhe Biotechnology CO., LTD. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 31 May 2024	25/05	CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2024	28/04	CI
Tranche Update on Jinhe Biotechnology CO., LTD.'s Equity Buyback Plan announced on February 6, 2024.	03/04	CI
Jinhe Biotechnology CO., LTD. announces an Equity Buyback for CNY 100 million worth of its shares.	05/02	CI
Jinhe Biotechnology CO., LTD. authorizes a Buyback Plan.	05/02	CI
Jinhe Biotechnology Chairman Proposes Buyback of Up to 100 Million Yuan Shares	02/02	MT
Jinhe Biotechnology Gets Nod for Live Brucellosis Vaccine	10/11	MT
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2023	29/23/29	CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Half Year Ended June 30, 2023	22/23/22	CI
Jinhe Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 05 June 2023	31/23/31	CI
Jinhe Biotechnology CO., LTD. announced that it expects to receive CAD 124.8 million in funding from Jinhe Youben Biological Products Co., Ltd.	25/23/25	CI
Jinhe Biotechnology CO., LTD. Announces Board Election	16/23/16	CI
Jinhe Biotechnology CO., LTD. Approves Cash Dividend (Tax Included) for 2022	16/23/16	CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
Jinhe Biotechnology Co., Ltd. Announces Final Profit Distribution Proposal for 2022	25/23/25	CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2022	30/22/30	CI
Tranche Update on Jinhe Biotechnology CO., LTD.'s Equity Buyback Plan announced on May 26, 2022.	11/22/11	CI
Jinhe Biotechnology to Take Full Control of Environmental Protection Firm For $46 Million	12/22/12	MT
Jinhe Biotechnology CO., LTD. agreed to acquire 49% stake in Inner Mongolia Jinhe Environmental Protection Technology Co., Ltd. from and others for CNY 318 million.	10/22/10	CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Half Year Ended June 30, 2022	11/22/11	CI
Tranche Update on Jinhe Biotechnology CO., LTD.'s Equity Buyback Plan announced on May 26, 2022.	01/22/01	CI
Jinhe Biotechnology CO., LTD. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on May 12, 2022.	26/22/26	CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/22/28	CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Full Year Ended December 31, 2021	21/22/21	CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2021	25/21/25	CI

Chart Jinhe Biotechnology CO., LTD.

Duration

Period

More charts

Jinhe Biotechnology CO., LTD. is a China-based company principally engaged in the research, development, production and sale of pharmaceutical feed additives. The Company's main products include animal feed additives, veterinary drug additives, veterinary vaccines and veterinary drugs. The Company is also involved in processing of corn starch, as well as wastewater treatment business. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

22/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Veterinary Drugs

	1st Jan change	Capi.
JINHE BIOTECHNOLOGY CO., LTD.	-22.04%	395M
ELANCO ANIMAL HEALTH INCORPORATED	+21.01%	8.91B
BLUESTAR ADISSEO COMPANY	+21.62%	3.6B
VIRBAC	-5.56%	3.04B
VIMIAN GROUP AB	+13.68%	1.67B
VETOQUINOL SA	-5.27%	1.23B
JINYU BIO-TECHNOLOGY CO., LTD.	-29.81%	1.16B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-31.11%	1.15B
WUHAN KEQIAN BIOLOGY CO.,LTD	-22.47%	1.01B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-12.32%	916M

Veterinary Drugs